PM2.5 inhibits SOD1 expression by up-regulating microRNA-206 and promotes ROS accumulation and disease progression in asthmatic mice.

This study found the possible molecular mechanism of PM2.5 aggravating asthma, and miR-206 may be a potential target for asthma treatment. PMID: 31520993 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31520993?dopt=Abstract

Source: International Immunopharmacology - September 10, 2019 Category: Allergy & Immunology Authors: Wang L, Xu J, Liu H, Li J, Hao H Tags: Int Immunopharmacol Source Type: research